New daily pill TIX100 takes first step toward tackling obesity

NCT ID NCT07675590

Recruiting now Disease control Sponsor: TIXiMED, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This early-stage trial tests whether TIX100, a daily oral pill, is safe and tolerable in healthy adults who are overweight or obese. Over 28 days, participants receive either TIX100 or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is to gather initial safety data before larger studies can explore whether TIX100 might help with weight management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TIX100
What this could lead to: If safe and well-tolerated, TIX100 could be developed further as a daily oral treatment to help manage weight in people with overweight or obesity.
What could go wrong: This is a very early Phase 1 trial with only 18 healthy volunteers, focused on safety, not weight loss. The drug may not prove effective or could have side effects in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTH ADULT SUBJECTS OBESITY & OVERWEIGHT

Contacts and locations

Locations

ProSciento, INC
RECRUITING

Chula Vista, California, 91911, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.